Saptha Vijayan

Saptha Vijayan

Eisai - Tokyo / Japan
Medical and Health Sciences / Immunology
AD Scientific Index ID: 5105866
エーザイ
person_outline Saptha Vijayan's MOST POPULAR ARTICLES
1-) NLRC5/MHC class I transactivator is a target for immune evasion in cancer S Yoshihama, J Roszik, I Downs, TB Meissner, S Vijayan, B Chapuy, ... Proceedings of the National Academy of Sciences 113 (21), 5999-6004, 2016 2222016
2-) NLRC5/CITA: a key player in cancer immune surveillance S Yoshihama, S Vijayan, T Sidiq, KS Kobayashi Trends in cancer 3 (1), 28-38, 2017 612017
3-) CITA/NLRC5: a critical transcriptional regulator of MHC class I gene expression I Downs, S Vijayan, T Sidiq, KS Kobayashi Biofactors 42 (4), 349-357, 2016 482016
4-) Class I transactivator, NLRC5: a central player in the MHC class I pathway and cancer immune surveillanceS Vijayan, T Sidiq, S Yousuf, PJ van den Elsen, KS KobayashiImmunogenetics 71 (3), 273-282, 2019512019
5-) MHC class I transactivator NLRC5 in host immunity, cancer and beyondSX Cho, S Vijayan, JS Yoo, T Watanabe, R Ouda, N An, KS KobayashiImmunology 162 (3), 252-261, 2021342021